Total RNA (10 μg) isolated from cells was treated with 4 U TURBO™ DNase (Ambion) in the presence of RiboLock RNase Inhibitor (Thermo Fisher Scientific), according to the manufacturer's protocol. Phenol:chloroform extraction was then performed and RNA was precipitated with isopropanol. DNase-treated RNA (2 μg) was used for cDNA synthesis. Reverse transcription was carried out using a mixture of 50 pmol of an oligo(dT) primer, 250 ng of random primers (Invitrogen) and SuperScript III Reverse Transcriptase (Invitrogen) according to the manufacturer's guidelines, in a final volume of 20 μl. Samples were diluted 10-fold and mixed with 2.5 pmol of each qPCR primer (see Supplementary Table S2 for sequences), 0.5 μg bovine serum albumin and Platinum® Quantitative PCR SuperMix-UDG (Invitrogen), in a final volume of 10 μl. qPCR was carried out in a Roche LightCycler® 480 system. Negative controls (-RT) were included for each experiment and showed an insignificant background. GAPDH mRNA was used for normalization. Reaction specificity was confirmed by melting curve analysis. Analyses were conducted in triplicate.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.